Huihuang Yan, Ph.D.![]() Huihuang Yan, Ph.D.
Location:
Minnesota
SummaryChanges of epigenetic marks have been implicated in the initiation and progression of various cancers. Such epigenetic alterations involve the changes of histone modifications, nucleosome remodeling, DNA methylation and non-coding RNAs expression, rather than the changes of DNA sequence itself. Dr. Yan's research focuses on the characterization of possible epigenetic aberrations associated with human cancers, in particular with breast cancer. He is trying to integrate multiple types of large-scale genomic and epigenomic data generated from next-generation sequencing technologies, including SNPs, ChIP-Seq, DNase-Seq, RNA-Seq, miRNA-seq and Hi-C. His main goal is to understand which of the identified changes in DNA sequence might have led to the epigenetic misregulation in human cancers. Focus areas:
Significance to patient careThis research effort will result in the construction of comprehensive epigenomic landscapes, and the identification of the associations with collections of genetic variants and gene transcripts for a particular disease. Integration of these data with clinical information will greatly contribute to our understanding of how the alterations of chromatin states and their interplay disrupt the transcriptional regulation network, ultimately leading to cancer development. Therefore, the accumulation of such knowledge will be vital to the discovery of biomarkers for cancer diagnosis and to the development of effective treatment strategies. Recent publicationsSee a listing of my publications Education
Ph.D.
–
Genetics
M.S.
–
Quantitative Genetics and Biostatistics
B.S.
–
Crop science
|
LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE
Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.